Intended for healthcare professionals


Ranitidine: all products are out of stock as investigations continue

BMJ 2019; 367 doi: (Published 28 November 2019) Cite this as: BMJ 2019;367:l6746
  1. Elisabeth Mahase
  1. The BMJ

All ranitidine products (injectable and oral) are “expected to be out of stock with no date for resupply until further notice,” the Department of Health and Social Care has told doctors.1

In an updated statement, the department added injectable products to the list of ranitidine products that should no longer be prescribed. …

View Full Text

Log in

Log in through your institution


* For online subscription